Endocrinology, Vol 136, 3993-4003, Copyright © 1995 by Endocrine Society

ARTICLES

Luteotropic actions of placental lactogens at midpregnancy in the mouse

SS Galosy and F Talamantes
Department of Biology, Sinsheimer Laboratories, University of California, Santa Cruz 95064, USA.

In this study the luteotropic activity of mouse placental lactogen I (mPL-I) at midpregnancy was assessed using in vivo and in vitro methodologies. Ovaries from 10-day pregnant mice were enzymatically dispersed and plated on fibronectin-coated wells in serum-free medium. The percentage of ovarian cells that stained for the presence of 3 beta- hydroxysteroid dehydrogenase activity was 24.4 +/- 2.7% at the time of plating and remained constant (26.1 +/- 5.0%) after a 20-h attachment period. Two types of 3 beta-hydroxysteroid dehydrogenase-staining cells, with distinct differences in size and morphology, were present in the culture. Large luteal cells (26-45 microns) were characterized by a small round nucleus and spherical shape with abundant cytoplasm. In contrast, small luteal cells (< 20 microns) were stellate, with little cytoplasm and a large oval nucleus. Basal progesterone secretion was maintained without a change in cellular DNA content and cell number for 168 h of culture. Treatment of ovarian cells with mPL-I (0.05-10 micrograms/ml) caused a dose-dependent increase in the progesterone concentration in the medium. The magnitude and time course of mPL-I- stimulated progesterone accumulation in culture were dependent on the time after plating that mPL-I treatment was initiated. The effects of mPL-II and mouse PRL (mPRL) on progesterone production were similar to those of mPL-I. The ability of sera from 10-, 14-, and 17-day pregnant mice to maintain progesterone production in bromocryptine-treated hysterectomized mice was also examined. Mice were hysterectomized on day 9 of pregnancy, and serum progesterone, mPL-I, mPL-II, and mPRL concentrations were measured 72 h later. Twice daily injections of 0.5 ml day 10 pregnancy serum maintained the circulating progesterone concentration at values not different from those present at the time of hysterectomy. In contrast, serum progesterone concentrations were not maintained in mice treated with serum of 14- or 17-day pregnant mice or with saline. Depletion of mPL-I from day 10 pregnancy serum by affinity chromatography on an anti-mPL-I column removed all luteotropic activity, as determined by the inability of this modified serum to maintain the serum progesterone concentration in bromocryptine-treated hysterectomized mice. A similar pool of day 10 pregnancy serum chromatographed on a nonspecific IgG control column did maintain progesterone production, but at somewhat lower concentrations than those present at the time of surgery. These studies offer direct evidence that mPL-I and mPL-II are luteotropic and support progesterone production at midpregnancy in the mouse.

This article has been cited by other articles:

				C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF]

				K H Al-Gubory, S Camous, G Germain, P Bolifraud, A Nicole, and I Ceballos-Picot Reconsideration of the proposed luteotropic and luteoprotective actions of ovine placental lactogen in sheep: in vivo and in vitro studies. J. Endocrinol., March 1, 2006; 188(3): 559 - 568. [Abstract] [Full Text] [PDF]

				J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]

				A H K El-Hashash and S J Kimber Trophoblast differentiation in vitro: establishment and characterisation of a serum-free culture model for murine secondary trophoblast giant cells Reproduction, July 1, 2004; 128(1): 53 - 71. [Abstract] [Full Text] [PDF]

				C. J. Ormandy, M. Naylor, J. Harris, F. Robertson, N. D. Horseman, G. J. Lindeman, J. Visvader, and P. A. Kelly Investigation of the Transcriptional Changes Underlying Functional Defects in the Mammary Glands of Prolactin Receptor Knockout Mice Recent Prog. Horm. Res., January 1, 2003; 58(1): 297 - 323. [Abstract] [Full Text] [PDF]

				D. J. Toft, S. B. Rosenberg, G. Bergers, O. Volpert, and D. I. H. Linzer Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression PNAS, October 16, 2001; (2001) 231364798. [Abstract] [Full Text] [PDF]

				H. K. Deol, R. Varghese, G. F. Wagner, and G. E. DiMattia Dynamic Regulation of Mouse Ovarian Stanniocalcin Expression during Gestation and Lactation Endocrinology, September 1, 2000; 141(9): 3412 - 3421. [Abstract] [Full Text] [PDF]

				G. Dai, M. W. Wolfe, and M. J. Soares Distinct Regulatory Regions from the Prolactin-Like Protein C Variant Promoter Direct Trophoblast Giant Cell Versus Spongiotrophoblast Cell-Specific Expression Endocrinology, October 1, 1999; 140(10): 4691 - 4698. [Abstract] [Full Text]

				H. Müller, G. Dai, and M. J. Soares Placental Lactogen-I (PL-I) Target Tissues Identified with an Alkaline Phosphatase-PL-I Fusion Protein J. Histochem. Cytochem., June 1, 1998; 46(6): 737 - 744. [Abstract] [Full Text]

				C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]

				J. Lin, J. Poole, and D. I. H. Linzer Two Novel Members of the Prolactin/Growth Hormone Family Are Expressed in the Mouse Placenta Endocrinology, December 1, 1997; 138(12): 5535 - 5540. [Abstract] [Full Text] [PDF]

				G. Thordarson, S. Galosy, G. O. Gudmundsson, B. Newcomer, R. Sridaran, and F. Talamantes Interaction of Mouse Placental Lactogens and Androgens in Regulating Progesterone Release in Cultured Mouse Luteal Cells Endocrinology, August 1, 1997; 138(8): 3236 - 3241. [Abstract] [Full Text] [PDF]

				C J Ormandy, A Camus, J Barra, D Damotte, B Lucas, H Buteau, M Edery, N Brousse, C Babinet, N Binart, et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes & Dev., January 15, 1997; 11(2): 167 - 178. [Abstract] [PDF]

				D. J. Toft, S. B. Rosenberg, G. Bergers, O. Volpert, and D. I. H. Linzer Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression PNAS, November 6, 2001; 98(23): 13055 - 13059. [Abstract] [Full Text] [PDF]